Despite the distinctive clinical and electroencephalographic features known for five decades, even today, juvenile myoclonic epilepsy (JME) is frequently unrecognised and misdiagnosed in both developed and developing countries. Utilising 183 JME probands belonging to the South Indian state of Kerala, assembled through a tertiary referral centre for molecular genetic studies, we explored the phenotypic peculiarities, clinical genetics, and problems and pitfalls in the diagnosis of JME. At referral, only six (3.3%) patients carried the diagnostic label of JME, default in diagnosis resulted from failure to elicit the history of myoclonic jerks by the referring physicians. During the mean delay of 8.6 ± 7.0 years in diagnosing JME, seizure control in the majority was poor due to inappropriate antiepileptic drug (AED) therapy. A history of epileptic seizures was obtained in 6.2% of the first-degree and 2.2% of the second-degree relatives of the probands; 37.7 and 11.1% of them, respectively, were diagnosed as JME. Although most of the clinical features of our cohort were in accordance with the literature, two notable differences we observed were the relatively increased occurrence of absence seizures and low frequency of photoparoxysmal responses. Although the variability in the clinical characteristics of JME may be apparent due to differences in the ascertainment of the data, they may well be an expression of a true clinical heterogeneity, and are in accordance with the complex and variable mode of inheritance and conflicting linkage studies reported for this syndrome from different ethnic groups.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is a well-defined age-related idiopathic generalised epilepsy syndrome with an estimated prevalence of 0.5-1 per 1000 population 1 . Myoclonic jerks, frequently involving the upper extremities and occurring shortly after awakening and often precipitated by sleep deprivation and alcohol ingestion, are the characteristic features of the syndrome 1, 2 . The majority of patients seen in epilepsy clinics also have generalised tonic-clonic seizures (GTCS), and about one third of them report antecedent history of absence seizures. The age at onset is usually around puberty and a positive family history of epilepsy is obtained in nearly half of the patients. Individuals with JME have normal intellect and neurological examination. The characteristic interictal electroencephalographic (EEG) finding is paroxysmal, generalised, symmetric, fast, multiple spike and slow wave discharges over a normal background activity 1, 3 . Intermittent photic stimulation during EEG elicits photoparoxysmal response in approximately one third of patients 1, 3 . Antiepileptic drug (AED) treatment with valproate results in seizure freedom in the majority, but relapses are inevitable on AED discontinuation 4, 5 .
Despite these distinctive clinical and EEG features initially described nearly five decades ago 6 and recognised by the International League Against Epilepsy more than a decade ago 7 , even today, JME is frequently unrecognised and misdiagnosed in both developed 5, 8 and developing countries [9] [10] [11] . Lack of familiarity with the syndrome, failure in eliciting a history of myoclonic jerks, and misinterpretation of absences, asymmetric myoclonic jerks and focal EEG findings in favour of partial seizures have been found to be the factors responsible for the misdiagnosis of JME [12] [13] [14] [15] . However, with the documentation of a sizeable number of patients with JME in recent years from different parts of the world, variability in the phenotypic expression of this epilepsy syndrome is becoming increasingly apparent. JME with myoclonic jerks alone 16 , with onset very early in life, as well as in old age 17 , with focal EEG abnormalities 18 , and with resistance to valproate therapy 19, 20 have been recognised.
Although JME is one of the most genetically explored epileptic syndromes, no gene or mutation has so far been conclusively implicated in the pathogenesis of the syndrome 21 . While the presence of a susceptibility locus for JME in the short arm of chromosome 6 was observed in the majority of the United States and German families 22, 23 , linkage studies in families from the United Kingdom 24 , Sweden 25 and Spain 26 failed to find evidence for such a locus. Linkage of JME to a locus in the long arm of chromosome 15 has been suggested 27 and negated 28 by different investigators. Genetic heterogeneity could perhaps explain dissimilarities of the phenotypic expression of JME, as well as the conflicting linkage results from different populations. Ethnic background of the population, by contributing to heterogeneity in susceptibility alleles and polygenic effects, may contribute to genotypic and phenotypic heterogeneity.
We recruited, through a tertiary referral centre, for gene mapping studies, 183 probands with JME belonging to the South Indian state of Kerala. The present report has two principal objectives: (1) to describe the clinical and EEG features of this cohort, and to compare and contrast the data with those reported from other parts of the world, and (2) to explore the phenotypic peculiarities, clinical genetics, and problems and pitfalls in the diagnosis of JME among the Kerala population.
PATIENTS AND METHODS

Area of the study and medical organisation
This study was undertaken at the R. Madhavan Nair Center for Comprehensive Epilepsy Care attached to the Sree Chitra Tirunal Institute for Medical Sciences and Technology, a tertiary referral centre situated at Trivandrum, the capital city of Kerala. The state of Kerala, situated in the southwest coast of the Indian peninsula and inhabited by over 30 million people, is distinguished from the rest of India by the high level of literacy and health awareness of its population 29, 30 . Kerala, unlike other Indian states, enjoys an extensive health infrastructure that is well distributed all over the state and thereby ensuring easy accessibility to urban as well as rural population 30 .
Patient selection
The patients were selected from the epilepsy clinic by the three consultant neurologists (K.R., P.J.C. and P.N.S.), with special interest in epilepsy, at least two of whom independently examined the patients to verify the diagnosis. Routine 16-channel scalp EEG was performed during wakefulness and sleep after the patients were partially deprived of sleep during the previous night 31 . Intermittent photic stimulation was performed during EEG recording on all patients 32 .
Diagnostic criteria for JME
The criteria for inclusion were: (a) characteristic repetitive myoclonic jerks involving the upper extremities, occurring after awakening, without loss of consciousness; (b) age at onset of myoclonic seizures between 8 and 25 years; (c) normal background activity and paroxysmal generalised spike and wave discharges in the EEG; and (d) otherwise normal neurological status and intelligence. Abnormal EEG was utilised to support the diagnosis of JME, but was not a prerequisite for the diagnosis. Exclusion criteria were: (a) evidence of structural, metabolic or degenerative diseases of the brain; (b) atonic/astatic or tonic seizures; (c) stimulus-induced myoclonic jerks alone; (d) partial seizures of any form; and (e) family history of progressive myoclonus epilepsy.
RESULTS
The demographic, clinical and EEG features observed in our patients are summarised in Table 1 . We used mean ± standard deviation to define the dispersion.
Demographic data
The mean age of 183 JME probands (95 males, 88 females) at presentation was 24.4 ± 7.2 years. The distribution of patients according to the age at presentation is shown in Fig. 1 . At the time of recruitment, 54% of the patients were between the ages 20 and 30 years. 
Seizure data
The seizure characteristics are provided in Table 1 . All patients had myoclonic jerks, however, only in six (3.3%) of them, the referring doctors had elicited this history. One hundred and seventy (92.9%) patients had at least two episodes of GTCS at the time of recruitment; in 156 (85.3%) of them the GTCS oc- curred in the early morning. An antecedent history of febrile seizures was present in 18 (9.8%) of the JME probands. Fig. 2 shows different seizure types and their combinations we observed among our patients. Ten (5.5%) patients had myoclonic seizures alone. The mean age at onset of myoclonus in these patients was 15.4 ± 5.9 years and the mean delay between the onset of myoclonic jerks and diagnosis of JME was 9.9 ± 4.8 (median 10) years.
Precipitating factors
A majority of patients had their GTCS episodes related to sleep deprivation (Table 1 ). Poor AED compliance was responsible for GTCS in 38 (20.8%), watching television in 6 (3.3%) and alcohol in 3 (1.6%) patients.
EEG data
The EEG findings noted in our patients are summarised in Table 1 . Interictal epileptiform discharges in the form of spikes, multiple spikes and wave discharges occurred in the scalp EEG recordings in 148 (80.9%) patients, which were generalised in 62.3% of patients, and lateralized or focal in 18.6%. Photoparoxysmal response to intermittent photic stimulation was elicited in 18 (9.9%) patients. One hundred and forty-six (79.8%) patients were receiving valproate at the time of the EEG study. 
Pitfalls in the diagnosis
The diagnosis, when we initially saw the patients, is cited in Table 2 . Although a majority of patients were diagnosed as having an epileptic seizure disorder, only six (3.3%) patients carried the diagnostic label of JME. The mean delay in diagnosing JME was 8.6 ± 7.0 years. The maximum delay from onset to diagnosis was 32 years. One hundred and thirteen (61.7%) patients had consulted at least one qualified neurologist prior to enrolment at our centre.
Treatment and follow-up
At the time of referral to us, 61% of patients were on a combination of AEDs (Table 3) . We subsequently weaned them off other AEDs, and optimised on sodium valproate alone (85%) or a combination of valproate with clonazepam. At referral, all the patients had experienced at least one GTCS in the preceding 3 months. At the time of last follow-up, 98 (53.6%) patients were completely seizure-free for 2 years or more, and 152 (83.1%) did not have more than two GTCS in the preceding year. Common causes for seizure recurrence were sleep deprivation and noncompliance to AED. 
Family history
The distribution of seizures and epileptic syndromes among the 850 first-degree and 2013 second-degree relatives of the 183 JME probands are summarised in Table 4 . There was a positive family history of seizures in 84 families (46%). First-and second-degree family members were affected in 53 (6.2%) and 45 (2.2%) of total members, respectively. JME was found in 25.5% and other idiopathic generalised epilepsies in 30.6% of the total affected first-and second-degree relatives. The diagnosis was verified among affected relatives in 21 of the 25 with JME and 23 of the 30 with other idiopathic generalised epilepsies.
DISCUSSION
Based on this prospective study, undertaken through a tertiary care epilepsy centre, we wish to describe the problems and pitfalls in the diagnosis, phenotypic peculiarities, and clinical genetics of JME as seen in the population of Kerala, South India. 
Problems and pitfalls in the diagnosis
Several studies have observed delay in diagnosis of JME, ranging from a mean of 6.8 15 to 15.0 years 13 , both from developed 5, 13, 33 and developing countries 11, 15 . In a patient, who presents with a GTCS following sleep deprivation, only antecedent history of myoclonic jerks during wakefulness clearly support the diagnosis of JME, and delay in the diagnosis usually results from failure to elicit this history [12] [13] [14] [15] .
The state of Kerala is distinguished from the rest of India by the high level of literacy and health awareness of its population, and a comprehensive health care system easily accessible to the population 29, 30 . While there is 1 neurologist for 13 500 persons with epilepsy for the whole of India, this ratio for Kerala is 1 for 3000. Despite these demographic and medical attributes favouring an early diagnosis of JME in the Kerala population, we found little difference in pitfalls in diagnosis compared to the data from less developed regions. In our group of 183 patients, only 6 (3.3%) were diagnosed with JME when first referred to us; the average duration from onset of seizures to diagnosis of JME was 8.6 years. Over 60% of the patients had consulted at least one qualified neurologist. Effective AED therapy was delayed and seizure control was poor at the time of referral in nearly all the patients. Carbamazepine, which is known to exacerbate or precipitate absence and myoclonic seizures, and GTCS in JME patients 34 , was the commonest AED in use, more often in combination with other AEDs. After JME diagnosis was made and optimal treatment with valproate started, seizure control was achieved in over 80% of the patients.
A majority of patients with epilepsy in developing countries are treated and followed up by primary and secondary care physicians without specific training or expertise in this disorder. The need for educating the primary and secondary care physicians about the recent trends in the diagnosis and treatment of epilepsy cannot be overemphasised. In developing regions, even among the neurologists, the awareness about JME is poor. In a recent report from Sri Lanka, two third of the JME patients, like in our study, had remained undiagnosed despite already seen by at least one neurologist 11 .
Phenotypic peculiarities
A majority of the clinical and EEG features observed in our JME cohort were in accordance with literature 1-4, 10, 35 . Nearly 10% of our patients had antecedent history of febrile seizures, consistent with the rate of 12% reported for JME patients from Turkey 36 . Myoclonic jerks as the only seizure type noted in 5.5% of our patients have been reported to occur in 7-17% of JME probands 2, 16, 37 . We found abnormal EEGs, defined as those with spike and/or multiple spike-wave discharges, in 81% of our patients, consistent with 60-90% reported in the literature [1] [2] [3] . Nearly 20% of our patients exhibited focal or lateralized epileptiform discharges, which has been reported to occur in about one third of patients with JME 14, 18 . The two notable differences we observed were the relatively increased occurrence of absence seizures and low frequency of photoparoxysmal response among Kerala JME probands.
In our series the prevalence of absence was 40% when compared to 10-35% reported among patients belonging to different ethnic groups 2, 3, 35, 38 . Two other series from India found absences in 8% of JME probands from Delhi 39 and in 21% from Hyderabad 10 . The absences in JME are generally mild, relatively short and are often unnoticed by the patients and their relatives 40 . Although the low frequency of absence seizures among JME patients reported from certain geographical regions may most likely be due to incomplete ascertainment, it may well be an expression of the clinical heterogeneity of the syndrome in different ethnic groups.
The prevalence of photoparoxysmal response in JME patients has been observed to vary from 10 to 40% [1] [2] [3] . The frequency of photoparoxysmal response can be influenced by several factors, such as age, gender, race, environment, sleep deprivation, technique of intermittent photic stimulation, definition of photoparoxysmal response, and AED regimen 41 . Photosensitivity appears at the age of 12-14 years and disappears between the ages of 20 and 30 years in a proportion of patients 42 . In a recent study, out of 61 children with a diagnosis of JME with a median age of 13 (range 7-16) years, 55 (90%) were photosensitive 43 . Two thirds of the patients with photosensitivity are females 41, 42 . A single dose of valproate can suppress the photoparoxysmal response 44 .
Among our JME patients, we encountered photoparoxysmal response in 10%. A low prevalence of photoparoxysmal response among epilepsy patients has been observed in African and Asian populations 45, 46 , compared to Whites living in Western countries 41, 42, 47 . However, we have observed a prevalence of photoparoxysmal response of 3.5% in epilepsy patients from Kerala 32 , comparable to that reported form the Western countries. The mean age of JME patients in our study was 24.4 years, and nearly 80% were receiving valproate at the time of EEG study. We attribute these two factors responsible for the relatively low prevalence of photoparoxysmal response among our JME patients. However, studies involving JME patients from South India 10 , North India 39 and Japan 48 have noted a relatively low prevalence of photoparoxysmal response. The variability in the prevalence of photoparoxysmal response among JME patients from different ethnic groups may be yet another reflection of the genetic variability of this syndrome.
Clinical genetics JME is the most genetically explored epilepsy syndrome 21 . Forty-six percent of our patients had a positive family history, which is comparable to the reported rates of 24-44% from India 10, 39 and 25-65% from other nations [1] [2] [3] . In all series, including ours, generalised epilepsies and syndromes were more common than localisation-related epilepsies among affected relatives. First-degree relatives were threefold or more often affected as compared to second-degree relatives 35, 39 . We diagnosed JME in 25.5% of affected relatives, similar to the 19% noted in a North Indian series comprising larger number of patients and affected relatives 39 . In a study from Saudi Arabia 35 , a family history of epilepsy was detected in 66% of the probands, and 36% of the families had at least two members affected by JME; these higher figures compared to studies from other regions may be attributable to large family size and high degree of consanguinity in this Arab population. A potential methodological limitation of these studies, including ours, is the absence of controlled family data.
There are conflicting reports regarding mode of inheritance of JME. Based on the study of a threegeneration pedigree of 33 members, 10 of whom were diagnosed as JME, Serratosa et al. 49 suggested an autosomal dominant inheritance. Autosomal dominant inheritance was also noticed in a recently reported large French Canadian family 50 . In the Saudi Arabian population, Panayiotopoulos et al. 35 postulated an autosomal recessive inheritance for JME.
Although two different loci on chromosomes 6p 22, 23 and 15q 27 have been proposed to be carrying JME predisposing genes, no single gene or mutation has so far been consistently implicated in the pathogenesis of JME. Latest linkage studies point to a complex mode of inheritance that is dependent on two or more disease genes and interplay of modifier genes 21, 51 . It is likely that multiple genetic factors that influence the neuronal excitatory and inhibitory pathways may play a collective role in predisposing to JME and in expressing the differential phenotypic components of the syndrome 52 . Molecular genetic studies are in progress in our patient cohort, the results of which will be communicated later.
